Introduction {#Sec1}
============

Renal cell carcinoma (RCC) is the most lethal malignancy of urinary system tumors and has the second largest incidence with a higher incidence than prostate cancer and a slightly lower incidence than bladder cancer in North America and Europe \[[@CR1]\]. The incidence of asymptomatic small renal cell carcinoma and micro renal cell carcinoma has remarkably increased with the increasing use of imaging for other medical indications by incidental detection \[[@CR2]\].

Surgical resection was once the preferred treatment for renal tumors. Radical nephrectomy (RN) and partial nephrectomy (PN), which were first performed by Winfield in 1992, are the two main treatment options \[[@CR3]\]. PN is appropriate in carefully selected patients with RCC and can reduce the risk of chronic kidney disease (CKD), decrease overall and tumor-specific mortality, and improve long-term renal function compared with RN \[[@CR4]--[@CR6]\]. However, renal artery occlusion is often required, and the accompanying thermal ischemic injury is an important cause of postoperative acute renal failure or long-term CKD \[[@CR7]\]. Main renal artery occlusion is an extensive renal blood flow occlusion that blocks the blood supply of tumor and healthy nephrons, and the postoperative recovery of blood flow is bound to lead to the ischemia--reperfusion injury of healthy nephrons \[[@CR8]\]. Blocking the renal artery branch that supplies tumor blood with highly selective blockade technology and not blocking the renal artery trunk are safe and feasible in PN, because PN can maintain the normal blood supply of residual kidney tissues and causes no remarkable difference in total renal function \[[@CR9]\]. Trehan reported that off-clamp PN is associated with a considerably lower reduction in estimated glomerular filtration rate (eGFR) than on-clamp PN \[[@CR10]\]. Robotic partial nephrectomy (RPN) with sequential segmental renal artery (SRA) clamping represents a good alternative for selective patients with multiple ipsilateral renal tumors. Precise segmental artery clamping (SAC) with the guidance of dual-source computed tomography (DSCT) can maximize renal function preservation \[[@CR11]\]. Some studies in China reported that SAC is associated with decreased warm ischemia and appears promising in terms of preserving postoperative function \[[@CR12], [@CR13]\]. Segmental artery clamping (SAC) was preferred by many surgical doctors. Li and Zhang \[[@CR12]\] showed that SAC is safer and has better renal function preservation compared with main artery clamping (MAC) in PN by reviewing the previous literature \[[@CR13]\]. However, Taweemonkongsap showed that clamping techniques do not affect renal functions, and the complication rate is low even in a small volume center \[[@CR14]\]. Therefore, the advantages and disadvantages of SAC and MAC lack systemic elaborations. The indicators for MAC and SAC are unclear. Therefore, tracking and analyzing current research for powerful and systematic evidence are necessary.

In this study, we conducted a retrieval and systematic analysis of the latest literature using case-control studies associated with comparing the features of SAC and MAC. Thus, this study can provide bases for evidence-based medicine to provide better services in clinical diagnosis and treatment.

Methods {#Sec2}
=======

Search strategy and selection criterion {#Sec3}
---------------------------------------

This meta-analysis complied with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analyses. We selected relevant literature published from January 2008 to November 2019 by searching English and Chinese databases, including Cochrane Library, PubMed, Excerpt Medica Database, Web of Science, China National Knowledge Internet, VIP database, and WanFang database with the following text words and Medical Subject Heading (MeSH) terms: (Kidney neoplasms \[MeSH\] OR Renal tumor OR Kidney neoplasm OR Neoplasm, Kidney OR Renal neoplasms OR Neoplasm, Renal OR Neoplasms, Renal OR Renal neoplasm OR Neoplasms, Kidney OR Cancer of kidney OR Kidney cancers OR Renal cancer OR Cancer, Renal OR Cancers, Renal OR Renal cancers OR Cancer of the kidney OR Kidney cancer OR Cancer, Kidney OR Cancers, Kidney) AND (Partial nephrectomy OR Nephron sparing nephrectomy OR Nephron sparing surgery OR NSS) AND (Selective arterial clamping OR SAC OR Selective clamp OR Super-selective clamp OR Segmental artery clamp OR Zero ischemia) AND (Main arterial clamping OR MAC) AND (Comparative Study OR Comparative Studies \[MeSH\]). All eligible tests were considered for review regardless of language.

Inclusion and exclusion criteria {#Sec4}
--------------------------------

The patients included were diagnosed with renal tumors, including benign and malignant tumors, and underwent SAC or MAC. Review literature and studies that were not control--case studies were not included in the present study. Documents without the necessary information or containing incomplete basic information were excluded. Low-quality studies were also excluded.

Two researchers (Xu and Zhang) reviewed the related articles separately and extracted the data using a uniform standardized table made with Excel 2010. The researchers preliminarily screened the article titles and abstracts independently. The studies that met the criteria were included in this meta-analysis. Any disagreements were resolved by consulting another researcher (SX Xu) until an agreement was reached. The targeted outcome measures were operating time (OT), estimated blood loss (EBL), warm ischemia time (WIT), blood transfusion rate, length of hospital stay (LOS), postoperative complication rate, postoperative eGFR change value, and percentage decrease in eGFR. In the process of data extraction, the continuous variables expressed using median and quartile spacing were converted to approximate mean and standard deviation, respectively, according to the methods proposed by Luo and Wan, respectively.

Quality evaluation {#Sec5}
------------------

The quality of each eligible article was assessed using the Newcastle--Ottawa Quality Assessment Scale (NOS). The papers with scores above 8 points were considered to have high quality. The papers with scores 6--8 points were considered methodologically sound. The studies scoring under 5 points were considered to have low quality and excluded from the final meta-analysis.

Statistical analyses {#Sec6}
--------------------

Statistical analysis was performed with Stata software version 12.0 (2011) (Stata Corp, Colledge Station, TX, USA). The heterogeneity was assessed using the Cochrane's *Q* test and the inconsistency index value (*I*^2^). *I*^2^ was more than 50%, which indicated that there was obvious heterogeneity. A random-effects model was used. A fixed-effects model was used when *I*^2^ was less than 50%. Otherwise, Descriptive evaluation was adopted for outcome indicators that cannot be quantitatively evaluated. *Egger*'s linear regression test was used to judge publication bias when the number of studies was more than 10.

Results {#Sec7}
=======

Baseline characteristics of the eligible studies {#Sec8}
------------------------------------------------

A total of 429 studies were identified from a search of the aforementioned databases. Approximately 140 duplicate publications were eliminated after review. Finally, 32 studies, including 19 references in English and 13 references in Chinese, were included in this meta-analysis. These studies had a cumulative sample size of 3098, including 1289 cases in the SAC group and 1809 cases in the MAC group. The flow chart of the literature research phase is shown in Fig. [1](#Fig1){ref-type="fig"}. In terms of NOS scores, nine articles had six marks, 11 articles had seven marks, and 12 articles had eight marks. The basic information and NOS scores of the included literature are shown in Table [1](#Tab1){ref-type="table"}. All data retrieved from the reviewed studies and recorded in an electronic database were as follows: demographic characteristics (age, sex, and body mass index), preoperative eGFR, tumor size (maximum diameter), and RENAL marks. The demographic data are shown in Table [2](#Tab2){ref-type="table"}. No significant difference in demographic data was observed between the two groups. Fig. 1Flow chart of the included literatureTable 1Basic information and remarks of the included papersStudyYearType of studyLanguageSACMACOperation methodsObserved indicatorsLength of follow upNOS marksOverall conclusion in SAC compared with MACDaniele Mattevi2018Case-controlEnglish4215RPN①②③④⑦⑧1Mos8Equivalent ①②③④⑦⑧Tawatchai Taweemonkongsap2018Case-controlEnglish3827RPN①②③④⑤18.2Mos8Equivalent ①②③④⑤, less number of patients with prolonged WITGang Xu2018Case-controlChinese2531LPN①②③⑥3Mos8Equivalent ①②③⑥, superior postoperative renal functionPengtao Wei2018Case-controlChinese2936LPN①②③⑤⑦3Mos7Equivalent ②③⑤⑦, more①, superior postoperative renal functionYongjian Zhang2018Case-controlChinese2822LPN①②⑤3days7More ①③, equivalent ②, superior postoperative renal functionDeZhu Qi2017Case-controlChinese3132LPN①②④⑤⑥12Mos8Equivalent ②④⑤⑥, more①, superior postoperative renal functionQian Cai2017Randomized controlled trialChinese1519LPN①②⑤6Mos8Equivalent ②, more ①③, postoperative renal functionPaulucci2016Propensity-score analysisEnglish66132RPN①②③⑤⑥⑦24Mos7Equivalent ①②③⑤⑥⑦Pu Li2016English314152LPN①②⑥70Mos8Equivalent ①②⑥, postoperative renal functionFurukawa2016Case-controlEnglish1920RPN①②⑤⑧1Mo7Equivalent ①②⑤⑧, postoperative renal functionKomninos2015Case-controlEnglish25114RPN①④⑤⑥⑦47Mos8Equivalent ①④⑤⑥⑦, superior postoperative renal functionShin2015Case-controlEnglish2097RPN③⑤⑥⑦3Mos7Equivalent ③⑤⑥⑦, postoperative renal functionAkca2015Case-controlEnglish111468RPN①②③⑤⑥⑦6Mos7Less ①, equivalent ②③⑤⑥⑦Wu Wei2015Case-controlChinese3943LPN②③⑤⑥⑦42Mos6Equivalent②③⑤⑥⑦, postoperative renal function.JianZhou Liu2015Case-controlChinese2927LPN①②⑤⑦36Mos6Equivalent ⑤⑦, more①②, superior postoperative renal functionPeng Li2015Case-controlChinese1013LPN①④⑤⑥3Mos8More ①④, equivalent⑤⑥, superior postoperative renal functionYuan Ruan2016Case-controlChinese4545LPN①②⑤22.5Mos7Equivalent in ①⑤, less②, superior postoperative renal functionHao Yang2015Case-controlChinese3545LPN②24Mos6Less ②, superior postoperative renal functionJianFeng Zhao2015Case-controlChinese2121LPN①②③④⑤⑥⑦Not mentioned6More ①, equivalent ②③④⑤⑥⑦, superior early renal functionLiYong Xing2014Case-controlChinese2728LPN①⑤⑥Not mentioned6Equivalent①⑤⑥Harke2014Case-controlEnglish1515RPN①②⑤⑥8days7Equivalent ①②⑤⑥, superior postoperative renal functionMcClintock2014Case-controlEnglish4242RPN①②⑤⑦3Mos8Equivalent ①②⑤⑦, superior postoperative renal functionYue Gao2014Case-controlChinese2138LPN②③⑤⑥⑦12Mos6More①,equivalent ③⑤⑥⑦, superior postoperative renal functionSiMei Zhu2014Case-controlChinese1344LPN①②⑤⑥⑦6Mos7Equivalent ①⑤⑥⑦, more②, superior postoperative renal functionDesai2014Case-controlEnglish5863RPN①③④⑤⑥⑦6Mos7Longer①, more④, equivalent in ③⑤⑥⑦, superior renal functionSheng Li2014Case-controlChinese1838LPN②③④⑤⑦4Mos6Equivalent ②③④⑤⑦, superior postoperative renal functionBorofsky2013Case-controlEnglish2727RPN①③④⑤⑥1Mos8Equivalent ①③④⑤⑥, superior postoperative renal functionMartin2012Case-controlEnglish1332RPN①③⑤⑥3Mos7Equivalent ①③⑤⑥JianGang Gao2012Case-controlChinese4237LPN①②③④⑤⑥⑦⑧48Mos6More ①, less②, eqiuvalent ③, superior postoperative renal functionNg2012Case-controlEnglish2222RPN①②③④⑤⑥⑦⑧2Mos8Equivalent①②③④⑤⑥⑦⑧.Pengfei Shao2011Case-controlEnglish3137LPN①②⑤⑥33Mos8Equivalent ①②⑤⑥, superior early postoperative affected renal functionNohara2008Case-controlEnglish1827Not mentioned①②⑤8Mos6Equivalent ①②⑤, superior postoperative renal functionNote: ① OT, ② WIT, ③ PSM, ④ blood transfusion rate, ⑤ EBL, ⑥ postoperative complications (Hemorrhage, hematuria, urine leak) ⑦ LOS, ⑧ Clavien classification (≥ 3)Table 2Meta-analysis of demographics of the patients of the included studiesIndicatorsNumber of studiesNumber of SACNumber of MACHeterogeneity analysis*χ*^2^df*I*^2^*P* valueOR/SMD (95CI)*P* valueMale2210721541157.902186.700.31− 0.41(− 0.39, 0.118)0.27BMI (kg/m^2^)219791441122.302083.600.00− 0.71(− 0.41, 0.07)0.16RENAL scores16841126880.401581.300.000.15(− 0.09, 0.40)0.21Tumor size(cm)2210001504157.982186.700.00− 0.14(− 0.40, 0.40)0.29Preoperative eGFR (mL/min/1.73 m^2^)2169413640.00200.001.000.0(− 0.105, 0.105)1.00

Sensitivity analysis {#Sec9}
--------------------

Sensitivity analysis (Table [3](#Tab3){ref-type="table"}) showed that OT, EBL, percentage of postoperative change in eGFR (1 week, 1 month, 3 months, and 6 months), positive surgery margin (PSM), blood transfusion rate, Clavien classification (≥ 3), and postoperative complications (hemorrhage, hematuria, and urine leak) in the two models were not remarkably different. Therefore, the results regarding these parameters were stable and reliable. By contrast, the results on WIT and LOS were unreliable (Table [3](#Tab3){ref-type="table"}). Table 3The pooled effect of outcome indicatorsOutcome indicatorsSMD/OR95%CIZ value*P*值Operation timeLPN1.170.75, 1.585.540.000RPN0− 0.38, 0.3800.911Overall0.560.25, 0.873.550.000Warm ischemia timeLPN0.12− 0.25, 0.490.630.530RPN− 0.07− 0.42, 0.280.380.702Overall0.04− 0.21, 0.280.30.761Estimated blood lossLPN0.650.35, 0.954.290.000RPN0.410.11, 0.712.70.007Overall0.550.34, 0.755.10.000Length of hospital stayLPN− 0.131− 0.355, 0.0921.150.317RPN0.152− 0.019, 0.3221.740.182Overall− 0.006− 0.166, 0.1540.080.0601-week postoperative change percentage in eGFR− 0.97− 1.41, − 0.534.320.0001-month postoperative change percentage in eGFR− 0.41− 0.77, − 0.052.250.0253-month postoperative change percentage in eGFR− 0.26− 0.59, 0.071.540.1246-month postoperative change percentage in eGFR− 0.08− 0.40, 0.560.330.741Positive surgical margin1.1730.547, 2.5170.410.908Blood transfusion rate1.0650.610, 1.8600.220.825Clavien classification(≥ 3)0.890.507, 1.5640.40.686Postoperative complications (hemorrhage, hematuria, urine leak )0.8160.601, 1.1071.310.191

Publication bias {#Sec10}
----------------

Publication bias for OT, LOS, percentage of postoperative change in eGFR (1 week, 1 month, 3 months, and 6 months), PSM, blood transfusion rate, Clavien classification (≥ 3), and postoperative complications (hemorrhage, hematuria, and urine leak) was assessed by Egger linear regression. The *P* values of OT, EBL, and LOS were less than 0.05, which suggested the presence of publication bias. The *P* values of the other parameters were greater than 0.05, which indicated no possibility of publication bias. The results are shown in Table [4](#Tab4){ref-type="table"}. Table 4Egger linear regression results of outcome indicatorsOutcome indicators*P* value of *Egger* testOperation time0.027Warm ischaemia time0.287Estimated blood loss0.012Length of hospital stay0.0081-week postoperative change percentage in eGFR0.4571-month postoperative change percentage in eGFR0.7443-month postoperative change percentage in eGFR0.1266-month postoperative change percentage in eGFR0.898Positive surgical margin0.827Blood transfusion rate0.953Clavien classification (≥ 3)0.176Postoperative complications (hemorrhage, hematuria, urine leak )0.314

### OT {#FPar1}

Thirty articles \[[@CR12]--[@CR41]\] were included in the literature. These studies showed heterogeneity (*I*^2^ = 92.3%, *P* = 0.000). Therefore, subgroup analysis was made according to different operation methods, namely laparoscopic partial nephrectomy (LPN) and robotic partial nephrectomy (RPN). Minimal heterogeneity was observed between the groups; thus, the operation method was not the main source of the heterogeneity. A random-effect model was used to pool the effectors. The result (Fig. [2](#Fig2){ref-type="fig"}) showed that OT was higher in the SAC group than in the MAC group (SMD = 0.56; 95% CI = 0.25, 0.87; *I*^2^ = 92.3%; *P* = 0.000), and no difference in OT was observed between SAC and MAC in the RPN group (SMD = 0.00; 95% CI = − 0.38, 0.38; *I*^2^ = 90.3%; *P* = 0.000). Fig. 2Forest plot and meta-analysis of the OT between the SAC and MAC groups

### WIT {#FPar2}

Twenty-five articles \[[@CR12]--[@CR23], [@CR26]--[@CR29], [@CR31]--[@CR34], [@CR37], [@CR39], [@CR42], [@CR43]\] were included in the literature, and these studies showed heterogeneity (*I*^2^ = 86.4%, *P* = 0.000). Therefore, subgroup analysis was performed according to the different operation methods, LPN and RPN. Slight heterogeneity was found in the different groups, so the operation method was not the main source of heterogeneity. A random-effect model was used to pool the effectors, and the result (Fig. [3](#Fig3){ref-type="fig"}) showed no significant difference in the overall WIT between the SAC and MAC groups (SMD = 0.04; 95% CI = − 0.21, 0.28; *I*^2^ = 86.4%; *P* = 0.000). Fig. 3Forest plot and meta-analysis of the WIT between the SAC and MAC groups

### EBL {#FPar3}

Thirty articles \[[@CR12]--[@CR40], [@CR43], [@CR44]\] were included, and these studies showed severe heterogeneity (*I*^2^ = 84.3%, *P* = 0.000). Therefore, subgroup analysis was made according to the different operation methods, LPN and RPN. The heterogeneity in the different groups changed slightly; thus, the operation method was not the main source of heterogeneity. A random-effect model was then used to pool the effectors. The result (Fig. [4](#Fig4){ref-type="fig"}) showed that EBL was higher in the SAC group than in the MAC group (SMD = 0.55; 95% CI = 0.34, 0.75; *I*^2^ = 84.3%; *P* = 0.000). Fig. 4Forest plot and meta-analysis of the EBL between the SAC and MAC groups

### Blood transfusion rate {#FPar4}

Twelve articles \[[@CR12]--[@CR14], [@CR24], [@CR26], [@CR29], [@CR30], [@CR33], [@CR35], [@CR37], [@CR43], [@CR44]\] were included, and they showed no heterogeneity (*I*^2^ = 0, *P* = 0.922). Therefore, a fixed-effect model was used. The results (Fig. [5](#Fig5){ref-type="fig"}) revealed no significant difference in the blood transfusion rate between the SAC and MAC groups (odds ratio \[OR\] = 1.065; 95% CI = 0.610, 1.860; *I*^2^ = 0; *P* = 0.922). Fig. 5Forest plot and meta-analysis of the blood transfusion rate between the SAC and MAC groups

### LOS {#FPar5}

Fifteen articles \[[@CR16], [@CR18], [@CR20], [@CR24], [@CR26], [@CR30], [@CR31], [@CR33]--[@CR35], [@CR38], [@CR42], [@CR43]\] were included, and they showed mild heterogeneity (*I*^2^ = 39.1%, *P* = 0.060). Subgroup analysis was performed according to the operation methods (LPN and RPN). *I*^2^ value was reduced to some extent in the subgroups; therefore, the operation method was partly the source of the heterogeneity. The results (Fig. [6](#Fig6){ref-type="fig"}) showed no significant difference in the LOS between SAC and MAC in the LPN (SMD = − 0.006; 95% CI = − 0.166, 0.154; *I*^2^ = 39.1%; *P* = 0.060) and RPN groups (SMD = 0.152; 95% CI = − 0.019, 0.322; *I*^2^ = 15.2; *P* = 0.317). Fig. 6Forest plot and meta-analysis of the LOS between the SAC and MAC groups

### Postoperative complications (hemorrhage, hematuria, and urine leak) {#FPar6}

Twenty-four articles \[[@CR12], [@CR13], [@CR15], [@CR18]--[@CR22], [@CR24], [@CR26]--[@CR35], [@CR37], [@CR38], [@CR42]--[@CR45]\] were included, and they had no heterogeneity (*I*^2^ = 0, *P* = 1.00). Therefore, a fixed-effect model was used. The result (Fig. [7](#Fig7){ref-type="fig"}) showed no significant difference in the postoperative complications between the SAC and MAC groups (OR = 0.82; 95% CI = 0.60, 1.11; *P* = 0.191). Fig. 7Forest plot and meta-analysis of the postoperative complication rate between the SAC and MAC groups

### Clavien classification (≥ 3) {#FPar7}

Fifteen articles \[[@CR13], [@CR14], [@CR19], [@CR27]--[@CR31], [@CR33]--[@CR35], [@CR37], [@CR38], [@CR44], [@CR45]\] were included, and no heterogeneity was found among the studies (*I*^2^ = 0, *P* = 0.983). Therefore, a fixed-effect model was used. The result (Fig. [8](#Fig8){ref-type="fig"}) showed no significant difference in the Clavien classification between the SAC and MAC groups (OR = 0.89; 95% CI = 0.51, 1.56; *I*^2^ = 0; *P* = 0.983). Fig. 8Forest plot and meta-analysis of the Clavien classification (≥ 3) between the SAC and MAC groups

### PSM {#FPar8}

Twenty-three articles \[14--17, 20--22, 24, 26, 27, 29--35, 37, 38, 43--45\]were included. No heterogeneity was observed among the studies (*I*^2^ = 0, *P* = 0.908), so a fixed-effect model was used. The result (Fig. [9](#Fig9){ref-type="fig"}) showed no significant difference in the PSM between the SAC and MAC groups (OR = 1.17; 95% CI = 0.55, 2.52; *P* = 0.908). Fig. 9Forest plot and meta-analysis of the PSM between the SAC and MAC groups

### One-week postoperative change percentage in eGFR {#FPar9}

Eight articles \[[@CR15], [@CR28]--[@CR30], [@CR32], [@CR33], [@CR35], [@CR42]\] were included, and severe heterogeneity was observed among the studies (*I*^2^ = 80.7%, *P* = 0.000). Subgroup analysis was performed according to the operation methods, LPN and RPN. *I*^2^ value was reduced to some extent in the subgroups; therefore, the operation method was partly the heterogeneity source. The result (Fig. [10](#Fig10){ref-type="fig"}) showed that the SAC group had a lower change in eGFR than the MAC group in the LPN (SMD = − 1.95; 95% CI = − 2.90, − 1.01; *I*^2^ = 62.5%; *P* = 0.103) and the RPN groups (SMD = − 0.69; 95% CI = − 1.00, − 0.38; *I*^2^ = 56.7%; *P* = 0.041) 1 week after the operation. Fig. 10Forest plot and meta-analysis of the 1-week postoperative change percentage in the eGFR between the SAC and MAC groups

### One-month postoperative change percentage in eGFR {#FPar10}

Six articles \[[@CR27]--[@CR29], [@CR32], [@CR33], [@CR45]\] were included, and they showed moderate heterogeneity (*I*^2^ = 62.7%, *P* = 0.020). Therefore, a random-effect model was used. The result (Fig. [11](#Fig11){ref-type="fig"}) showed that the SAC group had a lower change in eGFR than the MAC group 1 month after the operation (SMD = − 0.41; 95% CI = − 0.77, − 0.05; *P* = 0.025). Fig. 11Forest plot and meta-analysis of the 1-month postoperative change percentage in the eGFR in the SAC and MAC groups

### Three-month postoperative change percentage in the total eGFR of both kidneys {#FPar11}

Six articles \[[@CR19], [@CR27], [@CR29], [@CR30], [@CR33], [@CR42]\] were included and showed severe heterogeneity (*I*^2^ = 72.0%, *P* = 0.003). Subgroup analysis was performed according to the operation methods, LPN and RPN. *I*^2^ value was changed to some extent in the subgroups; therefore, the operation method was the source of heterogeneity in the LPN group but not in the RPN group. A random-effect model was used, and the result (Fig. [12](#Fig12){ref-type="fig"}) showed that the postoperative change percentages in the eGFR between the SAC and MAC groups at 3 months after the operation were not significantly different (SMD = − 0.35; 95% CI = − 0.72, 0.03). Fig. 12Forest plot and meta-analysis of the 3-month postoperative change percentage in the total eGFR between the SAC and MAC groups

### Three-month postoperative change percentage in the eGFR of the affected kidney {#FPar12}

Three articles \[[@CR12], [@CR13], [@CR34]\] were compared, and they and they exhibited severe heterogeneity (*I*^2^ = 87.7%, *P* = 0.003). Therefore, a random-effect model was used. The result (Fig. [13](#Fig13){ref-type="fig"}) showed that the 3-month postoperative change percentage in the eGFR of the affected kidney was lower in the SAC group than in the MAC group (SMD = − 0.662; 95% CI = − 0.840, − 0.484; *P* = 0.000). Fig. 13Forest plot and meta-analysis of the 3-month postoperative change percentage in the eGFR of the affected kidney between the SAC and MAC groups

### Six-month postoperative change percentage in the eGFR of both kidneys {#FPar13}

Four articles \[[@CR19], [@CR29], [@CR31], [@CR35]\] were included, and the articles had severe heterogeneity (*I*^2^ = 84.0%, *P* = 0.000). Therefore, a random-effect model was used. The result (Fig. [14](#Fig14){ref-type="fig"}) showed no significant difference in the 6-month postoperative change percentage in the eGFR between the SAC and MAC groups (SMD = 0.081; 95% CI = − 0.398, 0.560; *P* = 0.741). Fig. 14Forest plot and meta-analysis of the 6-month postoperative change percentage in the eGFR between the SAC and MAC groups

Discussion {#Sec11}
==========

In the current study, we systemically evaluated the effect of SAC and MAC on OT, EBL, WIT, LOS, postoperative complication rate, and postoperative percentage decrease in eGFR. The doctors conducted a case--control study by dividing the patients into the SAC and MAC groups. However, some patients included in the SAC group were subjected to MAC because of excessive bleeding from the defect, insufficient time to modulate the clamped branches, or no satisfactory ischemic area was obtained by clamping multiple branches. The two operations can be interchanged when necessary. Shao et al. first reported the nephrectomy of selectively blocking the renal artery and learned that SAC retains the affected nephrons and reduces the disadvantages of renal ischemic injury \[[@CR13]\]. RPN with SRA clamping under the guidance of DSCT and skilled robotic experience is feasible and can maximize renal function preservation \[[@CR46]\]. However, large-scale multicenter clinical studies are still needed to further prove these results.

Our results showed that OT was slightly longer in the LPN with SAC group than in the LPN with MAC group, whereas no difference was observed in the RPN group. PN with SAC requires the separation of the anterior and posterior branches of the renal artery and segmental renal arteries compared with traditional PN with MAC. The kidney should be slightly cut open to separate the third- and fourth-grade renal artery branches when necessary. Doing so requires additional steps and prolongs surgery. The duration of vessel separation during surgery is related to the doctor's skill and familiarity with the anatomical location of blood vessels. In addition to the duration of surgery, WIT was emphasized because it is a key factor that affects renal function.

Ischemia--reperfusion injury is a major cause of acute ischemic renal injury. Temporarily blocking the renal pedicle vessels is necessary during PN to control intraoperative hemorrhage and maintain clear vision, but this procedure can cause renal ischemia--reperfusion injury \[[@CR47]\]. LPN is widely used in the surgical treatment of renal tumors because of its safe and effective minimally invasive features. LPN with MAC has a good operative field, but long-term heat ischemia will cause damage to renal function \[[@CR48], [@CR49]\]. Benway showed that branch occlusion remarkably reduces thermal ischemia--reperfusion injury in a pig kidney model \[[@CR50]\]. Selective renal artery branch blocking technology has been gradually used in PN. The technology only blocks the renal artery branch that supplies blood to the tumor and can effectively avoid or reduce thermal ischemia injury in the normal renal unit. A WIT over 30 min will produce irreversible damage to kidney function. However, WIT is difficult to control in deeper positions, especially for cases in which the drainage system should be sutured. This meta-analysis showed that OT was longer in the SAC group than in the MAC group in LPN, but no significant difference was observed in the OT between the SAC and MAC groups in RPN. In addition, no significant difference was observed in the WIT between the SAC and MAC groups. LOS is affected by several factors, including a patient's condition. Our study showed no obvious difference in LOS between PN with SAC and PN with MAC; thus, PN with SAC did not affect LOS.

The results showed that EBL was greater in the SAC group than in the MAC group (*P* = 0.000). However, no significant difference was observed in the blood transfusion rate between the SAC and MAC groups. The combined effect indicator showed a difference between the two groups, but the amount of bleeding is commonly associated with a doctor's experience and skill. The kind of operation adopted depends on the ability of the doctor and the patient's condition. Seventeen of 23 articles showed that none of the patients had PSM. The remaining six articles showed no difference in PSM between the SAC and MAC groups. The combined effect indicator also proved that no difference was observed between the two groups (*P* = 0.8). Thus, no remarkable difference was found in the postoperative complications (hemorrhage, hematuria, and urine leak) and Clavien classifications (≥ 3) between the SAC and MAC groups. Heterogeneity analysis showed no heterogeneity among these studies.

The eight articles \[[@CR15], [@CR28]--[@CR30], [@CR32], [@CR33], [@CR35], [@CR40]\] related to 1-week postoperative change percentage in eGFR, which were eligible for this meta-analysis, indicated that the SAC group had lower changes than the MAC group in LPN and RPN. The six articles \[[@CR27]--[@CR29], [@CR32], [@CR33], [@CR36]\] related to the 1-month postoperative change percentage in eGFR indicated that the SAC group had lower changes than the MAC group. The six articles \[[@CR19], [@CR27], [@CR29], [@CR30], [@CR33], [@CR42]\] related to the 3-month postoperative change percentage in the total eGFR of both kidneys indicated that the SAC and MAC groups had no significant difference in postoperative change in eGFR after 3 months of operation. The three articles \[[@CR12], [@CR13], [@CR34]\] related to the 3-month postoperative change percentage in the eGFR of the affected kidney showed severe heterogeneity and indicated that the SAC group had lower changes in eGFR than the MAC group after 3 months of operation. The four articles \[[@CR19], [@CR29], [@CR31], [@CR35]\] related to the 6-month postoperative change percentage in the total eGFR of both kidneys showed severe heterogeneity and indicated that the two groups had no significant difference in eGFR change after 6 months of operation.

The number of articles investigating eGFR change ranged from 3 to 10. Our study showed that SAC reduced the percentage change in eGFR within 3 months but had no obvious effect on eGFR in 6 months. An analysis of eGFR change beyond 6 months was not carried out because of the lack of related literature. No kidney function loss by 18 months (median) of follow up was observed in T Taweemonkongsap's study. The present study suggested that SAC had a certain advantage in the short-term recovery of renal function, and this finding requires more random clinical experiments for verification. Our study results provide a basis for surgeons to actively screen and adapt patients to perform branch occlusion. Some patients might be good candidates for SAC. The patients with a tumor near the center of the renal hilum and those with large tumors may benefit from SAC. Komninos \[[@CR29]\] suggested that patients who have tumors near the renal hilum, a solitary kidney, or preoperative renal damage are suitable for SAC. Desai \[[@CR35]\] reported that interior, central, and bipolar tumors are suitable for SAC. Martin \[[@CR37]\] indicated that SAC is easier to conduct on the right side because the right main renal artery is longer and offers more space for branch dissection than the left side.

Deficiencies {#Sec12}
============

A large number of literature have been searched according to the inclusion and exclusion criteria; however, most of the studies included in this paper were not (RCTs), and many of the data were expressed in different ways. Some data were calculated by transforming the median and quartile into mean and standard deviation, respectively. Different articles varied in the expression index of kidney function. Some studies used eGFR, whereas others used blood creatinine; therefore, merging the data was difficult. And the surgeon experience, volume, as well as the closure technique cannot be controlled in the analysis. Moreover, the research results showed publication bias in three indicators.

Conclusion {#Sec13}
==========

The current result suggests that SAC is superior to MAC in terms of short-term postoperative renal function recovery. SAC is safe for selective patients when performed by a skilled surgeon. No clear differences in OT, WIT, LOS, blood transfusion rate, and postoperative complications were observed when compared with the alternative (i.e., SAC vs. MAC). However, RCTs are needed to support these preliminary findings.

CI

:   Confidence interval

SMD

:   Standard mean deviation

SAC

:   Segmental artery clamping

MAC

:   Main artery clamping

PN

:   Partial nephrectomy

PSM

:   Positive surgery margin

eGFR

:   Estimated glomerular filtration rate

OT

:   Operation time

WIT

:   Warm ischemia time

LOS

:   Length of hospital stay
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